Polyrizon Ltd. (PLRZ)
Nasdaq: PLRZ · Surgical & Medical Instruments & Apparatus · filing with the SEC since 2022
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Mar 25, 2026 | Mar 11, 2025 | · | · |
| Research and development | 2,133 | 534 | 332 | 347 |
| General and administrative | 4,116 | 768 | 303 | 548 |
| Operating income | -6,249 | -1,302 | -635 | -895 |
| Interest income (expense), net | -370 | · | · | · |
| Other income (expense), net | -2,914 | 243 | -35 | -116 |
| Total non-operating income (expense) | -2,914 | 243 | -35 | -116 |
| Net income | -3,335 | -1,545 | -600 | -779 |
| Net income to common shareholders | 3,335 | 1,605 | 669 | 823 |
| Earnings per share, basic | 4.90 | 805.20r | 494.40r | 0.60 |
| Earnings per share, diluted | 4.90 | 805.20r | 494.40r | 0.60 |
| Weighted average shares, basic | 680,380 | 1,994r | 1,354r | 1,305,635 |
| Weighted average shares, diluted | 680,380 | 1,994,000rb | 1,354r | 1,305,635 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding